PTC299
PTC299-ONC-003-BRC
Phase 1 small_molecule completed
Quick answer
PTC299 for Metastatic Breast Cancer is a Phase 1 program (small_molecule) at PTC THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PTC THERAPEUTICS, INC.
- Indication
- Metastatic Breast Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed